+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The anticholinergic risk scale and anticholinergic adverse effects in older persons



The anticholinergic risk scale and anticholinergic adverse effects in older persons



Archives of Internal Medicine 168(5): 508-513



Adverse effects of anticholinergic medications may contribute to events such as falls, delirium, and cognitive impairment in older patients. To further assess this risk, we developed the Anticholinergic Risk Scale (ARS), a ranked categorical list of commonly prescribed medications with anticholinergic potential. The objective of this study was to determine if the ARS score could be used to predict the risk of anticholinergic adverse effects in a geriatric evaluation and management (GEM) cohort and in a primary care cohort. Medical records of 132 GEM patients were reviewed retrospectively for medications included on the ARS and their resultant possible anticholinergic adverse effects. Prospectively, we enrolled 117 patients, 65 years or older, in primary care clinics; performed medication reconciliation; and asked about anticholinergic adverse effects. The relationship between the ARS score and the risk of anticholinergic adverse effects was assessed using Poisson regression analysis. Higher ARS scores were associated with increased risk of anticholinergic adverse effects in the GEM cohort (crude relative risk [RR], 1.5; 95% confidence interval [CI], 1.3-1.8) and in the primary care cohort (crude RR, 1.9; 95% CI, 1.5-2.4). After adjustment for age and the number of medications, higher ARS scores increased the risk of anticholinergic adverse effects in the GEM cohort (adjusted RR, 1.3; 95% CI, 1.1-1.6; c statistic, 0.74) and in the primary care cohort (adjusted RR, 1.9; 95% CI, 1.5-2.5; c statistic, 0.77). Higher ARS scores are associated with statistically significantly increased risk of anticholinergic adverse effects in older patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 021887394

Download citation: RISBibTeXText

PMID: 18332297

DOI: 10.1001/archinternmed.2007.106


Related references

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. Bmc Geriatrics 15: 31, 2016

Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study. Drugs and Aging 30(11): 927-934, 2014

Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs and Aging 30(2): 103-112, 2013

Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale. Drugs & Aging 30(2): 103-112, 2013

Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. American Journal of Geriatric PharmacoTherapy 4(1): 42-51, 2006

Audit of anticholinergic medication changes in older hospitalised patients using the Anticholinergic Drug Scale. Internal Medicine Journal 47(6): 689-694, 2017

Associations between the anticholinergic risk scale score and physical function: potential implications for adverse outcomes in older hospitalized patients. Journal of the American Medical Directors Association 12(8): 565-572, 2012

Anticholinergic Risk and Frequency of Anticholinergic Drug Prescriptions in a Population Older Than 65. Journal of the American Medical Directors Association 17(3): 275.E1-4, 2016

Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study. Drugs and Aging 30(5): 321-330, 2013

The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. Journal of Clinical Pharmacology 46(12): 1481-1486, 2006

The problems of anticholinergic adverse effects in older patients. Drugs and Aging 3(4): 335-348, 1993

Serum anticholinergic activity may not be related to anticholinergic medication use in ill elderly persons. Journal of Investigative Medicine 44(3): 307A, 1996

Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. Journal of the American Geriatrics Society 63(1): 85-90, 2015

Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients. Zdravstveno Varstvo 57(3): 140-147, 2018

Use of drugs with anticholinergic effects and cognitive impairment in community-living older persons. Age and Ageing 38(1): 105-108, 2008